IDEXX Laboratories (IDXX) analyst forecast and price target
Analyst forecast
Consensus of 17 analyst ratings
Based on 3 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Keybanc | Initiated Coverage | Sector Weight | — | Oct 12, 2026 |
| Barclays | Maintained | Overweight | $710.00 from $800.00 | Aug 11, 2026 |
| Citigroup | Maintained | Neutral | $670.00 from $650.00 | Aug 5, 2026 |
| UBS | Maintained | Neutral | $670.00 from $620.00 | Aug 5, 2026 |
| UBS | Maintained | Neutral | $620.00 from $640.00 | Jul 27, 2026 |
| UBS | Maintained | Neutral | $640.00 from $730.00 | Apr 28, 2026 |
| Citigroup | Initiated Coverage | Neutral | $650.00 | Apr 15, 2026 |
| Stifel | Maintained | Buy | $675.00 from $775.00 | Mar 31, 2026 |
| Piper Sandler | Maintained | Neutral | $750.00 from $775.00 | Feb 9, 2026 |
| Barclays | Maintained | Overweight | $800.00 from $850.00 | Feb 5, 2026 |
| BTIG | Maintained | Buy | $800.00 from $830.00 | Feb 3, 2026 |
| UBS | Maintained | Neutral | $730.00 from $750.00 | Feb 3, 2026 |
| Barclays | Initiated Coverage | Overweight | $850.00 | Dec 9, 2025 |
| BTIG | Maintained | Buy | $830.00 from $785.00 | Nov 4, 2025 |
| JP Morgan | Maintained | Overweight | $775.00 from $675.00 | Nov 4, 2025 |
| UBS | Maintained | Neutral | $750.00 from $710.00 | Nov 4, 2025 |
| Morgan Stanley | Maintained | Overweight | $805.00 from $765.00 | Nov 4, 2025 |
| Stifel | Upgraded | Hold → Buy | $700.00 from $640.00 | Oct 31, 2025 |
| UBS | Initiated Coverage | Neutral | $720.00 | Oct 1, 2025 |
| Morgan Stanley | Maintained | Overweight | $765.00 from $722.00 | Aug 15, 2025 |
Frequently asked questions
What is the price target for IDXX stock?
The average 12-month analyst price target for IDEXX Laboratories (IDXX) is $683.33, with a high estimate of $710.00 and a low of $670.00, across 3 analysts.
Is IDXX a buy, sell, or hold?
Analysts covering IDEXX Laboratories currently average a Buy rating: 9 buy, 7 hold and 1 sell, from 17 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for IDXX?
The average price target of $683.33 implies 29.17% upside from the last price of $529.01.
What is the latest analyst rating on IDXX?
On Oct 12, 2026, Keybanc initiated coverage of IDEXX Laboratories at Sector Weight.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.